Literature DB >> 15071492

An analysis of tumor necrosis factor alpha gene polymorphisms and haplotypes with natural clearance of hepatitis C virus infection.

C L Thio1, J J Goedert, T Mosbruger, D Vlahov, S A Strathdee, S J O'Brien, J Astemborski, D L Thomas.   

Abstract

The cytokine tumor necrosis factor alpha (TNF-alpha) is important in generating an immune response against a hepatitis C virus (HCV) infection. The functions of TNF-alpha may be altered by single-nucleotide polymorphisms (SNPs) in its gene, TNF. We hypothesized that SNPs in TNF may be important in determining the outcome of an HCV infection. To test this hypothesis, we typed nine TNF SNPs in a cohort of individuals with well-defined HCV outcomes. Three of these SNPs were typed in a second cohort. Data were analyzed using logistic regression stratifying by ethnicity, since rates of HCV clearance differ in black subjects versus white subjects. The SNP -863A was associated with viral clearance in black subjects (odds ratios (OR) 0.52, 95% confidence interval (CI) 0.29-0.93). Furthermore, the common wild-type haplotype -863C/-308G was associated with viral persistence in black subjects (OR 1.91, 95% CI 1.24-2.95). These findings were independent of linkage with human leukocyte antigen (HLA) alleles. Further study of this polymorphism and haplotype is needed to understand these associations and the role of TNF-alpha in determining outcomes of HCV infection.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15071492     DOI: 10.1038/sj.gene.6364072

Source DB:  PubMed          Journal:  Genes Immun        ISSN: 1466-4879            Impact factor:   2.676


  12 in total

Review 1.  Host genetic basis for hepatitis C virus clearance: a role for blood collection centers.

Authors:  Suganya Selvarajah; Leslie H Tobler; Graham Simmons; Michael P Busch
Journal:  Curr Opin Hematol       Date:  2010-11       Impact factor: 3.284

2.  Patterns of nucleotide sequence variation in ICAM1 and TNF genes in twelve ethnic groups of India: roles of demographic history and natural selection.

Authors:  Sanghamitra Sengupta; Shabana Farheen; Neelanjana Mukherjee; Partha P Majumder
Journal:  J Genet       Date:  2007-12       Impact factor: 1.166

3.  Interleukin-28b: a key piece of the hepatitis C virus recovery puzzle.

Authors:  Chloe L Thio; David L Thomas
Journal:  Gastroenterology       Date:  2010-02-23       Impact factor: 22.682

4.  Hemophilic siblings with chronic hepatitis C: Familial aggregation of spontaneous and treatment-related viral clearance.

Authors:  Michael W Fried; Barbara L Kroner; Liliana R Preiss; Kirk Wilhelmsen; James J Goedert
Journal:  Gastroenterology       Date:  2006-09       Impact factor: 22.682

5.  Regulatory polymorphisms in the interleukin-18 promoter are associated with hepatitis C virus clearance.

Authors:  Ping An; Chloe L Thio; Gregory D Kirk; Sharyne Donfield; James J Goedert; Cheryl A Winkler
Journal:  J Infect Dis       Date:  2008-10-15       Impact factor: 5.226

Review 6.  Neuroimmune basis of methamphetamine toxicity.

Authors:  Jennifer M Loftis; Aaron Janowsky
Journal:  Int Rev Neurobiol       Date:  2014       Impact factor: 3.230

Review 7.  Mechanisms of HCV-induced liver cancer: what did we learn from in vitro and animal studies?

Authors:  Ivan Rusyn; Stanley M Lemon
Journal:  Cancer Lett       Date:  2013-07-18       Impact factor: 8.679

Review 8.  A comparative review of HLA associations with hepatitis B and C viral infections across global populations.

Authors:  Rashmi Singh; Rashmi Kaul; Anil Kaul; Khalid Khan
Journal:  World J Gastroenterol       Date:  2007-03-28       Impact factor: 5.742

9.  Factors associated with spontaneous clearance of hepatitis C virus among illicit drug users.

Authors:  Jason Grebely; Jesse D Raffa; Calvin Lai; Mel Krajden; Brian Conway; Mark W Tyndall
Journal:  Can J Gastroenterol       Date:  2007-07       Impact factor: 3.522

Review 10.  Hepatitis C infection in dialysis patients: a link to poor clinical outcome?

Authors:  Kamyar Kalantar-Zadeh; Eric S Daar; Viktor E Eysselein; Loren G Miller
Journal:  Int Urol Nephrol       Date:  2006-09-29       Impact factor: 2.266

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.